Wolverine Trading’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168K | Buy |
18,390
+6,755
| +58% | +$61.8K | ﹤0.01% | 1011 |
|
|
2025
Q1 | $96.3K | Buy |
+11,635
| New | +$96.3K | ﹤0.01% | 1143 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2270 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2117 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2031 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1991 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1955 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1941 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1940 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2071 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2160 |
|
|
2022
Q1 | – | Sell |
-10,763
| Closed | -$465K | – | 2420 |
|
|
2021
Q4 | $465K | Sell |
10,763
-4,530
| -30% | -$196K | ﹤0.01% | 895 |
|
|
2021
Q3 | $675K | Buy |
15,293
+2,312
| +18% | +$102K | ﹤0.01% | 856 |
|
|
2021
Q2 | $732K | Sell |
12,981
-2,769
| -18% | -$156K | ﹤0.01% | 770 |
|
|
2021
Q1 | $1.15M | Buy |
15,750
+9,199
| +140% | +$674K | ﹤0.01% | 558 |
|
|
2020
Q4 | $581K | Buy |
6,551
+1,009
| +18% | +$89.5K | ﹤0.01% | 765 |
|
|
2020
Q3 | $331K | Sell |
5,542
-580
| -9% | -$34.6K | ﹤0.01% | 806 |
|
|
2020
Q2 | $256K | Buy |
+6,122
| New | +$256K | ﹤0.01% | 892 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1918 |
|
|
2019
Q1 | – | Sell |
-5,111
| Closed | -$455K | – | 1912 |
|
|
2018
Q4 | $455K | Sell |
5,111
-3,049
| -37% | -$271K | ﹤0.01% | 674 |
|
|
2018
Q3 | $1.15M | Buy |
+8,160
| New | +$1.15M | ﹤0.01% | 474 |
|
|
2018
Q1 | – | Sell |
-9,798
| Closed | -$1.61M | – | 2060 |
|
|
2017
Q4 | $1.61M | Buy |
9,798
+814
| +9% | +$134K | 0.01% | 388 |
|
|
2017
Q3 | $560K | Buy |
8,984
+4,004
| +80% | +$250K | ﹤0.01% | 564 |
|
|
2017
Q2 | $393K | Buy |
+4,980
| New | +$393K | ﹤0.01% | 683 |
|
|
2017
Q1 | – | Sell |
-9,680
| Closed | -$494K | – | 1867 |
|
|
2016
Q4 | $494K | Buy |
9,680
+1,460
| +18% | +$74.5K | ﹤0.01% | 577 |
|
|
2016
Q3 | $374K | Buy |
+8,220
| New | +$374K | ﹤0.01% | 605 |
|